Allarity Therapeutics (ALLR) Retained Earnings (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Retained Earnings came in at $144.4 million in Q1 2026, up 218.65% YoY from $45.3 million in Q1 2025, and up 14242.51% on a QoQ basis from -$1.0 million in Q4 2025.
Allarity Therapeutics (ALLR) Retained Earnings (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Retained Earnings data on file, last reported at $144.4 million in Q1 2026.
- Quarterly Retained Earnings rose 218.65% year-over-year to $144.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $144.4 million (up 218.65% YoY) and the FY2025 annual result came in at -$1.0 million, down 100.78% from the prior year.
- Retained Earnings climbed to $144.4 million in Q1 2026, from -$1.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $144.4 million in Q1 2026 to a low of -$121.7 million in Q1 2025.
- A 5-year average of -$10.2 million and a median of -$2.3 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 19915.99% — and 2024, when it slumped 15330.77%.
- Tracing ALLR's Retained Earnings over 5 years: stood at -$82.6 million in 2022, then fell by 14.42% to -$94.5 million in 2023, then jumped by 238.83% to $131.1 million in 2024, then slumped by 100.78% to -$1.0 million in 2025, then surged by 14242.51% to $144.4 million in 2026.
- The last three Retained Earnings figures came in at $144.4 million (Q1 2026), -$1.0 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | 4.38 Bn |
| 10 | Allarity Therapeutics | 22.43 Mn | 22.43 Mn | - | 144.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.40 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -2.30 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Mar 31, 2025 | -121.70 Mn |
| Dec 31, 2024 | 131.13 Mn |
| Sep 30, 2024 | -111.50 Mn |
| Jun 30, 2024 | -99.92 Mn |
| Mar 31, 2024 | -98.29 Mn |
| Dec 31, 2023 | -94.45 Mn |
| Sep 30, 2023 | 88.37 Mn |
| Jun 30, 2023 | -88.28 Mn |
| Mar 31, 2023 | -637,000.00 |
| Dec 31, 2022 | -82.55 Mn |
| Sep 30, 2022 | 83.03 Mn |
| Jun 30, 2022 | -1.23 Mn |
| Mar 31, 2022 | 84.23 Mn |
| Dec 31, 2021 | 85.24 Mn |
| Sep 30, 2021 | -419,000.00 |
| Jun 30, 2021 | 4.28 Mn |